Q2 2021 ImpediMed Ltd Earnings Call Transcript
Thank you for standing by, and welcome to the ImpediMed Quarterly Results Investor Call, Q2 FY 2021. (Operator Instructions)
I would now like to hand the conference over to Mr. Richard Carreon, Managing Director and CEO. Please go ahead.
Thank you, Rachel. Welcome, everyone, and thank you for joining us today. We're hosting this conference call to discuss our 4C for the financial quarter ending December 31, 2020.
Joining us on the call today is Tim Cruickshank, our Chief Financial Officer; and Mike Bassett, our Senior Vice President of Corporate and Strategic Development.
I'll be referencing the 4C and speaking from the financial presentation, we lived this morning, Australian time. The presentation is a summary of the more detailed 4C. At the conclusion of my remarks, we will be taking questions. I'll begin on Page 3 of the financial presentation.
We had a very strong quarter across every aspect of our business despite the ongoing headwinds
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |